| 0 |
Tissue Factor Pathway Inhibitor Antagonist [EPC] |
1 |
0.0222 |
| 1 |
Radiographic Contrast Agent [EPC] |
6 |
0.0002 |
| 2 |
Antisense Oligonucleotide [EPC] |
2 |
0.0002 |
| 3 |
Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] |
1 |
0.0002 |
| 4 |
Typical Antipsychotic [EPC] |
3 |
0.0001 |
| 5 |
General Anesthetic [EPC] |
4 |
0.0001 |
| 6 |
Melatonin Receptor Agonist [EPC] |
1 |
0.0001 |
| 7 |
Antidote [EPC] |
4 |
0.0001 |
| 8 |
Catecholamine [EPC] |
5 |
0.0001 |
| 9 |
Penem Antibacterial [EPC] |
2 |
0.0001 |
| 10 |
Carbonic Anhydrase Inhibitor [EPC] |
1 |
0.0000 |
| 11 |
Glycopeptide Antibacterial [EPC] |
3 |
0.0000 |
| 12 |
Bile Acid [EPC] |
1 |
0.0000 |
| 13 |
Prostacyclin Receptor Agonist [EPC] |
1 |
0.0000 |
| 14 |
Macrolide Antimicrobial [EPC] |
2 |
0.0000 |
| 15 |
Dipeptidyl Peptidase 4 Inhibitor [EPC] |
1 |
0.0000 |
| 16 |
Aminoglycoside Antibacterial [EPC] |
1 |
0.0000 |
| 17 |
Dietary Cholesterol Absorption Inhibitor [EPC] |
2 |
0.0000 |
| 18 |
Insulin [EPC] |
1 |
0.0000 |
| 19 |
CTLA-4-directed Blocking Antibody [EPC] |
1 |
0.0000 |
| 20 |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
1 |
0.0000 |
| 21 |
Opioid Agonist [EPC] |
5 |
0.0000 |
| 22 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
2 |
0.0000 |
| 23 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
2 |
0.0000 |
| 24 |
Peroxisome Proliferator Receptor alpha Agonist [EPC] |
1 |
0.0000 |
| 25 |
Methylxanthine [EPC] |
1 |
0.0000 |
| 26 |
Sulfonylurea [EPC] |
2 |
0.0000 |
| 27 |
Phosphodiesterase 5 Inhibitor [EPC] |
2 |
0.0000 |
| 28 |
alpha-Adrenergic Blocker [EPC] |
2 |
0.0000 |
| 29 |
Mood Stabilizer [EPC] |
3 |
0.0000 |
| 30 |
Azole Antifungal [EPC] |
2 |
0.0000 |
| 31 |
Dihydrofolate Reductase Inhibitor Antibacterial [EPC] |
1 |
0.0000 |
| 32 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
1 |
0.0000 |
| 33 |
Purine Antimetabolite [EPC] |
1 |
0.0000 |
| 34 |
Aminosalicylate [EPC] |
1 |
0.0000 |
| 35 |
Dihydropyridine Calcium Channel Blocker [EPC] |
3 |
0.0000 |
| 36 |
Anti-epileptic Agent [EPC] |
2 |
0.0000 |
| 37 |
Insulin Analog [EPC] |
4 |
0.0000 |
| 38 |
Aromatase Inhibitor [EPC] |
1 |
0.0000 |
| 39 |
Platelet Aggregation Inhibitor [EPC] |
5 |
0.0000 |
| 40 |
Loop Diuretic [EPC] |
4 |
0.0000 |
| 41 |
P2Y12 Platelet Inhibitor [EPC] |
1 |
0.0000 |
| 42 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
1 |
0.0000 |
| 43 |
Aldosterone Antagonist [EPC] |
1 |
0.0000 |
| 44 |
Angiotensin 2 Receptor Blocker [EPC] |
2 |
0.0000 |
| 45 |
Xanthine Oxidase Inhibitor [EPC] |
1 |
0.0000 |
| 46 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
1 |
0.0000 |
| 47 |
HMG-CoA Reductase Inhibitor [EPC] |
2 |
0.0000 |
| 48 |
Endothelin Receptor Antagonist [EPC] |
1 |
0.0000 |
| 49 |
RANK Ligand Inhibitor [EPC] |
1 |
0.0000 |
| 50 |
GLP-1 Receptor Agonist [EPC] |
2 |
0.0000 |
| 51 |
Atypical Antipsychotic [EPC] |
2 |
0.0000 |
| 52 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
5 |
0.0000 |
| 53 |
Nucleoside Metabolic Inhibitor [EPC] |
1 |
0.0000 |
| 54 |
Factor Xa Inhibitor [EPC] |
1 |
0.0000 |
| 55 |
Proton Pump Inhibitor [EPC] |
2 |
0.0000 |
| 56 |
beta-Adrenergic Blocker [EPC] |
1 |
0.0000 |
| 57 |
Benzodiazepine [EPC] |
2 |
0.0000 |
| 58 |
Corticosteroid [EPC] |
3 |
0.0000 |
| 59 |
Tumor Necrosis Factor Blocker [EPC] |
2 |
0.0000 |